Hong Kong Aerospace & Defense Stock News

Legend Holdings recently announced that CEO and executive director Mr. LI Peng has resigned from the company, with Mr. YU Hao appointed as the new chief executive officer effective November 17, 2025. This leadership transition is particularly noteworthy due to Mr. YU's extensive background in technology research and innovation, highlighted by his previous role as managing director of the company's Innovation Center. We'll look at how the appointment of a technology-focused CEO could shape...

Robosense Technology (SEHK:2498) has just released its Q3 2025 results, posting revenue of 407.1 million CNY and basic EPS of -0.22 CNY. Over the last three quarters, revenue moved from 327.8 million CNY to 455.4 million CNY before settling at 407.1 million CNY, while EPS remained consistently negative. Despite ongoing losses, investors are closely watching for signs of margin recovery amid shifting top-line trends and significant market expectations. See our full analysis for Robosense...

Laopu Gold (SEHK:6181) announced two key moves at its recent EGM. The company approved an interim dividend and amendments to its Articles of Association. Both steps signal immediate implications for current shareholders. See our latest analysis for Laopu Gold. Laopu Gold’s recent board decisions seem to have reignited interest, as reflected in its remarkable year-to-date share price return of 142.62% and a one-year total shareholder return of 225.6%. While momentum has cooled a bit in the...

Vitasoy International Holdings (SEHK:345) has just released its H1 2026 earnings, reporting revenue of $6.1 billion HKD and basic EPS of 0.22 HKD for the trailing twelve months, while net income came in at 236 million HKD. Looking back, the company has seen revenue hold steady over recent periods, with $6.3 billion HKD in H2 2025 and $6.3 billion HKD in H1 2025. EPS moved from 0.22 HKD to 0.12 HKD through these intervals. Margins have become a bigger part of the story for investors, with...

Hong Kong Exchanges and Clearing (SEHK:388) shares have drawn investor attention following their recent price moves. Given the platform’s central role in Asia’s financial markets, these fluctuations are often viewed in relation to broader market trends. See our latest analysis for Hong Kong Exchanges and Clearing. After a remarkable rally earlier in the year, Hong Kong Exchanges and Clearing’s share price has cooled recently, with a 4.8% decline over the past month and a slight dip in the...

Amidst global concerns about AI valuations and economic uncertainties, Asian markets have mirrored some of the cautious sentiment seen in other regions. For investors interested in exploring smaller or newer companies, penny stocks continue to present intriguing opportunities despite their somewhat dated terminology. These stocks, often representing under-the-radar growth potential at lower price points, can offer significant upside when backed by strong financial health and solid fundamentals.

Semiconductor Manufacturing International (SEHK:981) just released its latest earnings, showing increased sales and net income for the nine months ending September 30, 2025. The company also projected stable or slightly higher revenue for the upcoming quarter. See our latest analysis for Semiconductor Manufacturing International. On the heels of stronger sales and upbeat guidance, Semiconductor Manufacturing International’s 1-year total shareholder return stands out at 167.9%, showing...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Smart Globe Holdings (HKG:1481) has had a great run on the share market with its stock up by a significant 223% over...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

There wouldn't be many who think Stella International Holdings Limited's ( HKG:1836 ) price-to-earnings (or "P/E...

China Supply Chain Holdings Limited ( HKG:3708 ) shares have continued their recent momentum with a 161% gain in the...

China Resources Gas Group Limited ( HKG:1193 ), might not be a large cap stock, but it saw a double-digit share price...

Want Want China Holdings Limited ( HKG:151 ) shareholders are probably feeling a little disappointed, since its shares...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") below 12x, you may consider...

With a median price-to-earnings (or "P/E") ratio of close to 12x in Hong Kong, you could be forgiven for feeling...

Beijing Beida Jade Bird Universal Sci-Tech Company Limited ( HKG:8095 ) shares have retraced a considerable 29% in the...

Amid global market fluctuations and AI-related concerns, the Asian markets have also experienced their share of volatility, with particular focus on technology valuations and economic stimulus measures. Despite these challenges, investors continue to explore opportunities in various sectors, including those offered by penny stocks. These smaller or newer companies can present significant potential when backed by solid financials, offering a chance to uncover hidden value in an ever-evolving...

On November 20, 2025, Agricultural Bank of China completed the issuance of RMB35.0 billion in Tier 2 capital notes across 10-year and 15-year tranches in the National Interbank Bond Market, with interest rates of 2.14% and 2.40% respectively and conditional redemption rights at specified anniversaries. This substantial capital raising strengthens the bank's regulatory capital base and highlights both robust investor demand and consistent regulatory support for its growth and risk management...

Zhejiang Leapmotor Technology recently announced its inclusion as a constituent stock of the Hang Seng TECH Index, effective December 8, 2025, marking an important recognition of its innovations in the technology and new energy vehicle space. This development is anticipated to expand the company's investor base, improve trading liquidity, and increase market visibility among global investors. We'll examine how Leapmotor's upcoming addition to the Hang Seng TECH Index could reinforce its...

Key Insights The considerable ownership by private companies in China Everbright Environment Group indicates that they...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

On November 18, 2025, Sino Biopharmaceutical announced that its subsidiary LaNova Medicines received clinical trial approval in China for LM-350, a CDH17-targeting antibody-drug conjugate aimed at treating multiple gastrointestinal cancers. This regulatory milestone marks further progress in Sino Biopharmaceutical's efforts to address significant unmet medical needs in the oncology sector through its innovative pipeline. We’ll examine how this clinical trial approval for LM-350 shapes Sino...

Key Insights The projected fair value for Alibaba Health Information Technology is HK$11.29 based on 2 Stage Free Cash...